ArticleCureus2026
Retroperitoneoscopic Approach in Live Donor Left Nephrectomy: Insights From a Single-Center Case Series in the Sub-Himalayan Region.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Living donor nephrectomy demands a surgical approach that ensures donor safety while preserving optimal graft function. The retroperitoneoscopic approach provides direct access to the renal hilum, potentially reducing bowel manipulation and postoperative morbidity. This study aimed to evaluate the feasibility, safety, and perioperative outcomes of laparoscopic retroperitoneoscopic donor nephrectomy (LRDN) in a small case series, with a particular emphasis on donor recovery and clinical outcomes. Methods From November 2022 to January 2023, seven patients underwent retroperitoneoscopic donor nephrectomy (RDN) performed by a single surgeon during the surgeon's initial independent experience, following participation in more than 100 RDN procedures at a high-volume center. All procedures were performed using a standardized retroperitoneoscopic approach. None of the donors had a history of previous abdominal surgery, and the retroperitoneoscopic approach was adopted as the standard technique. Perioperative parameters, including operative time, warm ischemia time, cold ischemia time, estimated blood loss, intraoperative complications, conversion to open surgery, length of hospital stay, and postoperative complications, were analyzed. Complications were graded according to the Clavien-Dindo classification. Donor recovery and outcomes were evaluated during the follow-up period. Results All seven procedures were successfully completed using the retroperitoneoscopic approach without conversion. The procedure was performed on the left side in all cases. The donor cohort comprised two males and five females, with a mean age of 46 years (range: 30-60 years). The mean operative time was 210 ± 22.9 minutes, with a mean estimated blood loss of 100.71 ± 16.94 mL. Three patients had two renal arteries. The mean warm ischemia time was 265 ± 21.41 seconds. The mean hospital stay was 3.86 ± 0.90 days. Donor recovery was uneventful in all patients, with no postoperative complications observed. Conclusions LRDN is a feasible and safe technique with favorable donor and graft outcomes based on the findings of this small case series. The procedure offers the advantages of minimal postoperative pain and rapid recovery, although it requires technical expertise and involves an associated learning curve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.